1-8 of 8
Nathalie Enjolras
Close
Sort by
Journal Articles

Extravascular Factor IX Pool Fed By Prophylaxis Is a True Hemostatic Barrier Against Bleeding

Alexandre Leuci, Nathalie Enjolras, Muriel Marano, Melanie Daniel, Marie Brevet, Philippe Connes, Yesim G. Dargaud
Journal: Blood
Blood (2023) 142 (Supplement 1): 5462.
https://doi.org/10.1182/blood-2023-179522
Published: 2023
Journal Articles

Hemostatic Effect of the Combination of Factor VIII Concentrate with Tranexamic Acid (TXA) in the Prophylactic Setting in Severe Hemophilia a

Maissaa Janbain, MD, Nathalie Enjolras, PhD, Jean-Claude Bordet, Radu Bolbos, Cindy A. Leissinger, MD, Yesim Dargaud, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2490.
https://doi.org/10.1182/blood-2018-99-119407
Published: 2018
Journal Articles

Genetic Fusion to Factor XIII B-Subunit Improves the Pharmacokinetic Properties of Factor IX

Sandra Le Quellec, MD, Nathalie Enjolras, PhD, Jean-Claude Bordet, Vladmir Jacqueline, Claude Negrier, MD, Yesim Dargaud, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2339.
https://doi.org/10.1182/blood.V130.Suppl_1.2339.2339
Published: 2017
Journal Articles

Individually Tailored By-Passing Therapy for the Management of Breakthrough Bleeds in Hemophilia Patients with Inhibitors Receiving Prophylaxis with Emicizumab

Yesim Dargaud, MD PhD, Anne Lienhart, MD, Nathalie Enjolras, PhD, Claude Negrier, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3675.
https://doi.org/10.1182/blood.V130.Suppl_1.3675.3675
Published: 2017
Journal Articles

Adeno-Associated Virus Mediated Gene Transfer with Hyperfunctional FIX-E410H Variant Improves Mean Factor IX Activity Levels in Hemophilia B Mice

Sandra Le Quellec, MD, Allison P Dane, PhD, Claude Negrier, Yesim Dargaud, MD PhD, Amit C Nathwani, MD PhD, Nathalie Enjolras, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4610.
https://doi.org/10.1182/blood.V130.Suppl_1.4610.4610
Published: 2017
Journal Articles

Hepatoma Cell Line HuH-7 : a Promising New Cellular System for Recombinant FIX Production.

Nathalie Enjolras, PhD, Yesim Dargaud, MD, PhD, Jean-Luc Plantier, PhD, Heli Simpson, Florine Guillaume, Claude Negrier, MD
Journal: Blood
Blood (2009) 114 (22): 4202.
https://doi.org/10.1182/blood.V114.22.4202.4202
Published: 2009
Journal Articles

Substitution of Four Residues Revealed by High-Throughput Screening of Human Factor VIII A2 Domain Generated a Recombinant Molecule That Escapes to Anti-Factor VIII Antibodies

Jean-Luc Plantier, Didier Saboulard, Marc Delcourt, Nathalie Enjolras, Claude Negrier, MD
Journal: Blood
Blood (2008) 112 (11): 3067.
https://doi.org/10.1182/blood.V112.11.3067.3067
Published: 2008
Journal Articles

Generation of Factor VIII Molecules Partially Resistant to Activated Protein C.

Veronique Rolli, Ph D, Nathalie Enjolras, PhD, Cecile Ducasse, Marie-Helene Rodriguez, PhD, Thomas Weimer, PhD, Hans-Peter Hauser, PhD, Claude Negrier, MD, PhD, Jean-Luc Plantier, Ph D
Journal: Blood
Blood (2004) 104 (11): 1729.
https://doi.org/10.1182/blood.V104.11.1729.1729
Published: 2004